Lönnberg S - Search Results

1

Zeptomole detection sensitivity of prostate-specific antigen in a rapid microtitre plate assay using time-resolved fluorescence.

Härmä H, Soukka T, Lönnberg S, Paukkunen J, Tarkkinen P, Lövgren T. Härmä H, et al. Among authors: lonnberg s. Luminescence. 2000 Nov-Dec;15(6):351-5. doi: 10.1002/1522-7243(200011/12)15:6<351::AID-BIO624>3.0.CO;2-3. Luminescence. 2000. PMID: 11114110

2

Supersensitive time-resolved immunofluorometric assay of free prostate-specific antigen with nanoparticle label technology.

Soukka T, Paukkunen J, Härmä H, Lönnberg S, Lindroos H, Lövgren T. Soukka T, et al. Among authors: lonnberg s. Clin Chem. 2001;47(7):1269-78. Clin Chem. 2001. PMID: 11427459

3

Qualitative detection of tetracycline residues in milk with a luminescence-based microbial method: the effect of milk composition and assay performance in relation to an immunoassay and a microbial inhibition assay.

Kurittu J, Lönnberg S, Virta M, Karp M. Kurittu J, et al. Among authors: lonnberg s. J Food Prot. 2000 Jul;63(7):953-7. doi: 10.4315/0362-028x-63.7.953. J Food Prot. 2000. PMID: 10914667 Free article.

4

A group-specific microbiological test for the detection of tetracycline residues in raw milk.

Kurittu J, Lönnberg S, Virta M, Karp M. Kurittu J, et al. Among authors: lonnberg s. J Agric Food Chem. 2000 Aug;48(8):3372-7. doi: 10.1021/jf9911794. J Agric Food Chem. 2000. PMID: 10956118

5

Large performance variation does not affect outcome in the Finnish cervical cancer screening programme.

Lönnberg S, Nieminen P, Kotaniemi-Talonen L, Kujari H, Melkko J, Granroth G, Vornanen M, Pietiläinen T, Arola J, Tarkkanen J, Luostarinen T, Anttila A. Lönnberg S, et al. Cytopathology. 2012 Jun;23(3):172-80. doi: 10.1111/j.1365-2303.2011.00849.x. Epub 2011 Jan 24. Cytopathology. 2012. PMID: 21255160

6

Validation of histological diagnoses in a national cervical screening register.

Lönnberg S, Leinonen M, Malila N, Anttila A. Lönnberg S, et al. Acta Oncol. 2012 Jan;51(1):37-44. doi: 10.3109/0284186X.2011.593547. Epub 2011 Aug 28. Acta Oncol. 2012. PMID: 21871004

7

Age-specific effectiveness of the Finnish cervical cancer screening programme.

Lönnberg S, Anttila A, Luostarinen T, Nieminen P. Lönnberg S, et al. Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1354-61. doi: 10.1158/1055-9965.EPI-12-0162. Epub 2012 Jun 4. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22665576

8

Mortality audit of the Finnish cervical cancer screening program.

Lönnberg S, Nieminen P, Luostarinen T, Anttila A. Lönnberg S, et al. Int J Cancer. 2013 May 1;132(9):2134-40. doi: 10.1002/ijc.27844. Epub 2012 Oct 12. Int J Cancer. 2013. PMID: 22987437

9

Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.

Leinonen MK, Nieminen P, Lönnberg S, Malila N, Hakama M, Pokhrel A, Laurila P, Tarkkanen J, Anttila A. Leinonen MK, et al. Among authors: lonnberg s. BMJ. 2012 Nov 29;345:e7789. doi: 10.1136/bmj.e7789. BMJ. 2012. PMID: 23197596 Free PMC article. Clinical Trial.

10

Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries.

Anttila A, Lönnberg S, Ponti A, Suonio E, Villain P, Coebergh JW, von Karsa L. Anttila A, et al. Among authors: lonnberg s. Eur J Cancer. 2015 Jan;51(2):241-51. doi: 10.1016/j.ejca.2014.10.022. Epub 2014 Dec 4. Eur J Cancer. 2015. PMID: 25483785 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters